Mustang Bio Dividend
Dividend criteria checks 0/6
Mustang Bio does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$3.22 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Mustang Bio: This Horse May Gallop Still
Sep 23Is Mustang Bio, Inc. (NASDAQ:MBIO) Trading At A 46% Discount?
Aug 09
Mustang Bio: The Market Is Missing This Opportunity
May 03Will Mustang Bio (NASDAQ:MBIO) Spend Its Cash Wisely?
Dec 29Mustang Bio: Remains Underfollowed Despite Moving Closer To Pivotal Studies
Sep 14Mustang Bio (MBIO) EHA Investor Presentations - Slideshow
Jun 18Mustang Bio jumps 7% on encouraging MB-106 safety and efficacy data in blood cancers
Jun 11Checking Back In On Mustang Bio
May 26FDA accepts Mustang Bio's MB-106 application in cancer
May 10Here's Why We're Watching Mustang Bio's (NASDAQ:MBIO) Cash Burn Situation
Mar 22What Type Of Shareholders Own The Most Number of Mustang Bio, Inc. (NASDAQ:MBIO) Shares?
Feb 23Mustang Bio, Inc.'s (NASDAQ:MBIO) Intrinsic Value Is Potentially 25% Below Its Share Price
Jan 28
Mustang Bio launches early-stage CAR T therapy study in brain tumor
Dec 21Lindsay Rosenwald Is The Non-Executive Director of Mustang Bio, Inc. (NASDAQ:MBIO) And They Just Picked Up 100% More Shares
Dec 18Mustang Bio gains after impressing with ASH presentation
Dec 07Is Mustang Bio (NASDAQ:MBIO) In A Good Position To Invest In Growth?
Dec 04Mustang Bio EPS beats by $0.02
Nov 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if MBIO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MBIO's dividend payments have been increasing.
Dividend Yield vs Market
| Mustang Bio Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (MBIO) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Biotechs) | 2.9% |
| Analyst forecast in 3 Years (MBIO) | n/a |
Notable Dividend: Unable to evaluate MBIO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MBIO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate MBIO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MBIO has not reported any payouts.